Pharmaceuticals

Veranova Proposes Closure of Annan Facility 

Veranova’s subsidiary, Macfarlan Smith, announced a proposal to close its Annan, UK facility.

Over the last several months, Veranova conducted a review of its manufacturing capacity relative to customer needs and market trends across its product portfolio.

As an outcome of this review, Veranova’s subsidiary, Macfarlan Smith, announced a proposal to close its Annan, UK facility. Macfarlan Smith recognizes the impact this proposal will have on staff at the Annan facility.

Niek Stapel, Veranova’s CEO said “Every effort has been made to avoid proposing the closure of the plant. This was a difficult decision to make which in no way reflects the performance or commitment of our colleagues at Annan.”

The proposed closure is subject to statutory consultation requirements under UK law.

About Veranova 

Veranova is a global leader in process development and manufacturing of APIs, with a focus on specialty and complex products. Veranova is headquartered in Wayne, PA and has operations in North America, Europe and Asia. For more information, please visit www.veranova.com

 

 

Contact Details 

For further information, please e-mail Andrew James at andrew.james@veranova.com.